| Trial Identifier: | D7551C00003 |
| Sponsor: | AstraZeneca |
| Collaborator: |
Parexel
|
| Start Date: | February 2021 |
| Primary Completion Date: | March 2021 |
| Study Completion Date: | March 2021 |
| Condition: | Chronic Kidney Diseases |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version |
| Country | Location |
|---|---|
| United Kingdom | London, United Kingdom, HA1 3UJ |